BERGER FRANKLIN M — SEC Form 4 filings

SEC reporting owner CIK 1273885. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-01-26 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Atea Pharmaceuticals, Inc. (AVIR)Director74 legs · 50,000 sh · $162,9971 leg · 359,606 sh · $1,023,47512
Kezar Life Sciences, Inc. (KZR)Director38
Rain Oncology Inc. (RAIN)Director14
ESSA Pharma Inc. (EPIX)Director22

Form 4 filings — BERGER FRANKLIN M

FiledFormIssuerReported transactionsSource
2026-06-234Atea Pharmaceuticals, Inc. (AVIR)Option exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-05-114Kezar Life Sciences, Inc. (KZR)Code (U): 89,069 · Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0EDGAR
2025-10-154ESSA Pharma Inc. (EPIX)Disposition to issuer (D): 784,404EDGAR
2025-06-244Atea Pharmaceuticals, Inc. (AVIR)Option exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0EDGAR
2025-06-234Kezar Life Sciences, Inc. (KZR)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2025-01-174/AAtea Pharmaceuticals, Inc. (AVIR)Purchase (P): 15,000 @ $3.19 · Purchase (P): 10,000 @ $3.36EDGAR
2025-01-174Atea Pharmaceuticals, Inc. (AVIR)Purchase (P): 15,000 @ $3.19 · Purchase (P): 10,000 @ $3.36EDGAR
2024-12-124Atea Pharmaceuticals, Inc. (AVIR)Sale (S): 359,606 @ $2.85EDGAR
2024-06-214Atea Pharmaceuticals, Inc. (AVIR)Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0EDGAR
2024-06-214Kezar Life Sciences, Inc. (KZR)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-184Atea Pharmaceuticals, Inc. (AVIR)Option exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0EDGAR
2024-03-284ESSA Pharma Inc. (EPIX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-01-264Rain Oncology Inc. (RAIN)Code (U): 1,005,207 · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1273885 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →